2025 Citroen C5 Aircross Unveiled; Gets EV Powertrain Option
Citroen has unveiled the new C5 Aircross. In this iteration, the vehicle has received a complete overhaul. For instance, it now comes with a new design, changes in the cabin, and a new powertrain. The major change in terms of powertrain is the addition of an all-electric version for the first time. This is because of Stellantis' new STLA medium architecture, which underpins a few models in the European market, like Peugeot 3008 and Vauxhall Grandland.
Starting with the design, the Citroen C5 Aircross' aesthetics are inspired by the concept car revealed by the automaker in 2024 at the Munich Motor Show. This can be seen in the form of a refreshed front fascia with a new design for the headlamps and DRLs. This contributes to making the front end completely new, mixed with the new design for the bumper. All of this is complemented by a new design for the 20-inch alloy wheels.
Also Read:
Carrying forward its boxy silhouette, the SUV has received changes to improve its aerodynamics aimed at improving efficiency. Furthermore, the length has now increased by 150 mm to 4,652 mm with an increase of 600 mm in wheelbase. Meanwhile, the rear end also gets a new design for the taillamps with a muscular look for the black cladding.
On the inside, the cabin has been completely changed to offer an upmarket feel. It now gets a floating screen in the centre, which can be customised. The brand has eliminated lots of physical buttons to use a touch-screen system.
The 2025 Citroen C5 Aircross has been launched with two hybrid options, one being mild and the other a plug-in hybrid. The mild hybrid combines a 1.2-litre three-cylinder petrol engine with a small electric motor in a dual-clutch transmission, supported by a 0.9kWh battery. The plug-in hybrid features a 1.6-litre four-cylinder petrol engine working alongside a 123 hp electric motor, resulting in a total output of 193 hp and a 21kWh battery that allows for an electric driving range of 85.
The electric C5 Aircross can be equipped with either a 73kWh battery that provides a range of 519 km or a 97kWh battery that offers 679 km, paired with a front motor producing either 207 hp or 227 hp.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
17 minutes ago
- Mint
Trump wants cheaper drugs like Europe has. How it works.
President Donald Trump doesn't just want to bring down prescription drug prices for Americans. He wants European countries to raise them to make up the revenue that drugmakers would lose from his policy. Trump is proposing a so-called most-favored-nation pricing model, which would set U.S. drug prices at the lowest level in other wealthy countries. But the pharmaceutical industry isn't buying into tying drug prices in the U.S. to prices in Europe—at least not knowing the details of the president's proposal. More details about the government's pricing model could come this week. On May 12, Trump directed government health officials to benchmark drug prices to international standards within 30 days. The lobbying group PhRMA, with members including U.S. pharma giants Eli Lilly, Pfizer, Johnson & Johnson, and AbbVie, has argued there are two reasons why U.S. drug prices are high: foreign countries not paying 'their fair share" for medicines, and middlemen such as pharmacy-benefit managers. Today, U.S. drug pricing is largely market driven. It involves negotiations between drug manufacturers, pharmacy-benefit managers, healthcare insurers and providers. European countries do it much differently. Each has its own way of determining drug prices, but most follow one of two broad approaches. The first approach, which Germany and France use, considers the overall clinical effectiveness of a new medicine. How does the new treatment compare to existing ones? Does it have added therapeutic benefits? If the new drug is substantially better, its price would reflect that. A second approach, used by the U.K., the Netherlands, and Sweden, analyzes cost effectiveness. This model not only compares the new drug to existing ones but also assesses the incremental value that the medicine brings to the health system. After the assessments, negotiations between drugmakers and the countries begin. Because many European countries have national health systems, they are in a strong negotiation position. If government negotiators think a medicine is too expensive for its effectiveness, they won't recommend its use. How Trump's MFN policy would work in practice isn't clear. Drug prices would probably be based on list prices in Europe since the prices paid by national health systems, or net prices, are confidential. The president's open-ended directive, laid out in an executive order, has many wondering how the U.S. could raise prices in Europe. Trump has made clear he wants to close the gap between U.S. and international prices, and has suggested he would use tariffs and export controls to achieve his goal. In theory, drugmakers could set list prices higher in Europe as long as it doesn't affect net prices, health policy expert Dr. Huseyin Naci told Barron's. In the U.K., for example, a higher list price could still lower the prices in other European countries. 'So that would still not be an acceptable approach to many other European countries," said Naci, who is associate professor of health policy at the London School of Economics. Overhauling Europe's decades-old pricing approaches would require fundamental changes to their pricing regulations—and there will be 'little appetite or ability" to alter them, Naci added. Cost is another complicating factor. 'Pharmaceutical spending is already one of the top categories of spending in many countries in terms of healthcare expenditure, so there's little room to accommodate higher prices and spending for pharmaceuticals in Europe," according to Naci. How Trump is planning to make Europeans pay more for drugs is the big question. He could use tariffs and trade negotiations as leverage. In early April, the president said a 'major" tax on pharmaceutical imports is coming 'very shortly," however nothing has been announced yet. In a trade agreement with the U.K. a month later, there is a provision on pharmaceuticals that states the U.K. will 'endeavor to improve the overall environment for pharmaceutical companies." What that means in practice still isn't clear. Write to Elsa Ohlen at
&w=3840&q=100)
First Post
33 minutes ago
- First Post
Does India trust Trump? It's not about personality X or president Y, says Jaishankar
External Affairs Minister Dr S. Jaishankar said India's relationship with the United States is extremely important, and it is not just about 'President X' when asked if New Delhi trusts Donald Trump read more External Affairs Minister Dr S. Jaishankar said the relationship with the United States is extremely important to India, regardless of who is the president of the country. The remarks from the Indian diplomat came in an interview with European news outlet Euractiv when he was asked about whether 'India trusts US President Donald Trump'. 'I take the world as I find it. Our aim is to advance every relationship that serves our interests, and the US relationship is of immense importance to us. It's not about personality X or president Y,' Jaishankar told the European news outlet. STORY CONTINUES BELOW THIS AD The conversation took place during Jaishankar's visit to Belgium's capital, Brussels, where he held talks with the leaders of the European Union. On Tuesday, he met EU Chief Ursula von der Leyen and EU Foreign Policy Minister Kaja Kallas as India and the EU negotiated the highly anticipated Free Trade Agreement. Where India stands in the geopolitical order When asked where India sees itself in the geopolitical order, Jaishankar emphasised how the world is becoming more multipolar. 'Multipolarity is already here. Europe now faces the need to make more decisions in its own interest – using its own capabilities, and based on the relationships it fosters globally,' the Indian external affairs minister told Euractiv. 'I hear terms like 'strategic autonomy' being used in Europe – these were once part of our vocabulary. The EU plays a major role in the global order and is increasingly an autonomous one. That is precisely why I'm here: to deepen our relationship in this multipolar world," he added. During the interview, Jaishankar admitted that Europe is becoming far more realistic lately. However, he maintained that India continues to have 'deep reservations' about the EU's Carbon Border Adjustment Mechanism (CBAM), which is the tax that the EU imposes on products from jurisdictions where climate policies are not robust. 'The idea that one part of the world will set standards for everybody else is something which we are against. We have very deep reservations about CBAM, and we've been quite open about it," the EAM explained. Jaishankar went on to reiterate Prime Minister Narendra Modi's promise of signing an India-EU FTA by the end of the year.
The Hindu
an hour ago
- The Hindu
Nvidia chief calls AI ‘the greatest equaliser' but warns Europe risks falling behind
Will artificial intelligence save humanity — or destroy it? Lift up the world's poorest — or tighten the grip of a tech elite? Jensen Huang, the global chip tycoon, offered his opinion on Wednesday: neither dystopia nor domination. AI, he said, is a tool for liberation. Wearing his signature biker jacket and mobbed by fans for selfies, the Nvidia CEO cut the figure of a tech rockstar as he took the stage at VivaTech in Paris. 'AI is the greatest equaliser of people the world has ever created,' Huang said, kicking off one of Europe's biggest technology industry fairs. But beyond the sheeny optics, Nvidia used the Paris summit to unveil a wave of infrastructure announcements across Europe, signaling a dramatic expansion of the AI chipmaker's physical and strategic footprint on the continent. In France, the company is deploying 18,000 of its new Blackwell chips with startup Mistral AI. In Germany, it's building an industrial AI cloud to support manufacturers. Similar rollouts are underway in Italy, Spain, Finland and the U.K., including a new AI lab in Britain. Other announcements include a partnership with AI startup Perplexity to bring sovereign AI models to European publishers and telecoms, a new cloud platform with Mistral AI, and work with BMW and Mercedes-Benz to train AI-powered robots for use in auto plants. The announcements reflect how central AI infrastructure has become to global strategy, and how Nvidia — the world's most valuable chipmaker — is positioning itself as the engine behind it. At the center of the debate is Huang's concept of the AI factory: not a plant that makes goods, but a vast data center that creates intelligence. These facilities train language models, simulate new drugs, detect cancer in scans, and more. Asked if such systems risk creating a 'technological priesthood' — hoarding computing power and stymying the bottom-up innovation that fueled the tech industry for the past 50 years — Huang pushed back. 'Through the velocity of our innovation, we democratise,' he told The Associated Press. 'We lower the cost of access to technology.' As Huang put it, these factories 'reason,' 'plan,' and 'spend a lot of time talking to' themselves, powering everything from ChatGPT to autonomous vehicles and diagnostics. But some critics warn that without guardrails, such all-seeing, self-reinforcing systems could go the way of Skynet in ' The Terminator ' movie — vast intelligence engines that outpace human control. 'Just as electricity powered the last industrial revolution, AI will power the next one,' he said. 'Every country now needs a national intelligence infrastructure.' He added: 'AI factories are now part of a country's infrastructure. That's why you see me running around the world talking to heads of state — they all want AI to be part of their infrastructure. They want AI to be a growth manufacturing industry for them.' Europe, long praised for its leadership on digital rights, now finds itself at a crossroads. As Brussels pushes forward with world-first AI regulations, some warn that over-caution could cost the bloc its place in the global race. With the U.S. and China surging ahead and most major AI firms based elsewhere, the risk isn't just falling behind — it's becoming irrelevant. Huang has a different vision: sovereign AI. Not isolation, but autonomy — building national AI systems aligned with local values, independent of foreign tech giants. 'The data belongs to you,' Huang said. 'It belongs to your people, your country... your culture, your history, your common sense.' But fears over AI misuse remain potent — from surveillance and deepfake propaganda to job losses and algorithmic discrimination. Huang doesn't deny the risks. But he insists the technology can be kept in check — by itself. 'In the future, the AI that is doing the task is going to be surrounded by 70 or 80 other AIs that are supervising it, observing it, guarding it, ensuring that it doesn't go off the rails.' The VivaTech event was part of Huang's broader European tour. He had already appeared at London Tech Week and is scheduled to visit Germany. In Paris, he joined French President Emmanuel Macron and Mistral AI CEO Arthur Mensch to reinforce his message that AI is now a national priority.
